Oct. 7 at 5:00 AM
$CLPT shares have surged 78% so far this year against the industry’s decline of 6.8% — what's driving this momentum? 🚀
The new Robotic Neuro-Navigation System positions ClearPoint in the booming cell and gene therapy market. While regulatory approvals are pending, the innovation could fuel long-term growth.
Discover the strategic impact here 👉 https://www.zacks.com/stock/news/2762453/clpt-expands-into-robotic-system-supporting-cell-and-gene-therapies?cid=sm-stocktwits-2-2762453-body-14693&ADID=SYND_STOCKTWITS_TWEET_2_2762453_BODY_14693